Illumina cuts annual profit forecast for second straight quarter
(Reuters) - U.S. genetic testing Illumina on Thursday trimmed its annual profit forecast for the second straight quarter, hurt by weakness in demand for its sequencing instruments, consumables and services.Shares of the San Diego,…